(Q28469093)

English

A comparative study on the cost of new antibiotics and drugs of other therapeutic categories

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

A comparative study on the cost of new antibiotics and drugs of other therapeutic categories (English)

0 references

1

Matthew E Falagas

0 references

Konstantinos N Fragoulis

series ordinal

2

object named as

Konstantinos N Fragoulis

0 references

author name string

Ioannis Karydis

series ordinal

3

0 references

language of work or name

English

0 references

publication date

20 December 2006

0 references

published in

PLOS One

0 references

volume

1

0 references

page(s)

e11

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

20 December 2006

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The price of innovation: new estimates of drug development costs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762307

retrieved

19 March 2017

Secular trends of antimicrobial resistance of blood isolates in a newly founded Greek hospital

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762307

retrieved

29 September 2017

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762307

retrieved

29 September 2017

The need for new therapeutic agents: what is the pipeline?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762307

retrieved

29 September 2017

New science-based endpoints to accelerate oncology drug development

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762307

retrieved

29 September 2017

Trends in antimicrobial drug development: implications for the future

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762307

retrieved

29 September 2017

The Costs of Conducting Clinical Research

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762307

retrieved

29 September 2017

Projecting future drug expenditures--2001.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762307

retrieved

29 September 2017

Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762307

retrieved

29 September 2017

Pharmacoeconomics: an emerging discipline.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1762307

retrieved

29 September 2017

World Wide Web resources on antimicrobial resistance.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0000011

retrieved

21 January 2018

Emerging role of pharmacoeconomics in the research and development decision-making process

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17183637

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The cost of chemotherapy]

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17183637

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1371/JOURNAL.PONE.0000011

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4318597

ADS bibcode

2006PLoSO...1...11F

0 references

OpenCitations bibliographic resource ID

4318597

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4318597

PubMed publication ID

17183637

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4318597

ResearchGate publication ID

6616083

0 references

(Q28469093)

A comparative study on the cost of new antibiotics and drugs of other therapeutic categories

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)